摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-chloro-1-cyclopropyl-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid | 93110-13-5

中文名称
——
中文别名
——
英文名称
7-chloro-1-cyclopropyl-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
英文别名
7-chloro-1-cyclopropyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;7-Chloro-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid;7-chloro-1-cyclopropyl-4-oxoquinoline-3-carboxylic acid
7-chloro-1-cyclopropyl-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid化学式
CAS
93110-13-5
化学式
C13H10ClNO3
mdl
——
分子量
263.68
InChiKey
PISYZMAJMMQIRQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    441.5±45.0 °C(Predicted)
  • 密度:
    1.586±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    57.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Microbicidal agents based on quinolonecarboxylic acid
    摘要:
    使用公式##STR1##中的1-环丙基-1,4-二氢-4-氧基-喹啉羧酸,特别是在农业中,与微生物作斗争,其中R.sup.1是氢、氟、氯、溴或硝基,R.sup.2是氢、氯、氟或基团##STR2##,特别是4-哌嗪基基团,或其酸加合物、碱金属、碱土金属或植物耐受的重金属盐,或其水合物。其中一些化合物是已知的。
    公开号:
    US04563459A1
  • 作为产物:
    描述:
    7-chloro-1-cyclopropyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methyl ester 在 盐酸 作用下, 以 乙醇 为溶剂, 反应 4.0h, 以91%的产率得到7-chloro-1-cyclopropyl-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
    参考文献:
    名称:
    Identification, biological activity, and mechanism of the anti-ischemic quinolone analog
    摘要:
    The quinolone analog SQ-4004 has been identified as a potentially excellent anti-ischemic agent, which exhibited highly potent efficacy in reducing infarct volume size in vivo rat MCAO model (32.1% at 0.01 mg/kg) and potent cardioprotective effect at myocardial infarction in vivo model (26.6% at 0.01 mg/kg) while it exhibited highly reduced anti-bacterial activity. The mechanistic study revealed that the anti-ischemic activity might exert via an anti-apoptotic pathway, which implies its therapeutic uses against the ischemic cell injuries including ischemic stroke and ischemic heart disease. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.07.009
点击查看最新优质反应信息

文献信息

  • Quinolonecarboxylic acids and antibacterial agents containing these
    申请人:Bayer Aktiengesellschaft
    公开号:US04559341A1
    公开(公告)日:1985-12-17
    The invention relates to quinolone carboxylic acids, pharmaceutical compositions containing said quinolone carboxylic acids and the use of said compounds and compositions for treatment of bacterial infection. Also included in the invention are process for the manufacture of the active quinolone carboxylic acids.
    这项发明涉及喹诺酮羧酸、含有该喹诺酮羧酸的药物组合物以及利用该化合物和组合物治疗细菌感染的用途。该发明还包括制造活性喹诺酮羧酸的方法。
  • [EN] ESTER LINKED MACROLIDES USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS<br/>[FR] MACROLIDES A LIAISON ESTER UTILES POUR LE TRAITEMENT D'INFECTION MICROBIENNES
    申请人:PLIVA ISTRAZIVACKI INST D O O
    公开号:WO2005108412A1
    公开(公告)日:2005-11-17
    The present invention relates to 14- or 15-membered macrolides substituted at the 4” position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infoections in a human or animal body.
    本发明涉及在式(I)的4”位置被取代的14-或15-环大环内酯及其药学上可接受的衍生物,以及它们的制备方法和在人体或动物体内治疗或预防全身或局部微生物感染中的用途。
  • Bactericidal agents
    申请人:Bayer Aktiengesellschaft
    公开号:US04563448A1
    公开(公告)日:1986-01-07
    A method of combating plant-pathogenic bacteria, comprising applying to the bacteria or to a bacteria habitat a bactericidally effective amount of a cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid derivative of the formula ##STR1## in which A represents straight-chain or branched alkylene with 1 to 6 carbon atoms or a >C.dbd.CH-- radical, R.sup.1 represents alkoxycarbonyl with 1 to 6 carbon atoms in the alkyl part, benzyloxycarbonyl, carboxyl, optionally substituted carbamoyl, cyano or dialkoxyphosphonyl or alkylsulphonyl with 1 to 4 carbon atoms in the alkyl part, and R.sup.2 represents hydrogen, alkoxycarbonyl with 1 to 6 carbon atoms in the alkyl part, benzyloxycarbonyl, optionally substituted carbamoyl, cyano, chlorine, acetyl, alkyl with 1 to 3 carbon atoms or phenyl, or R.sup.1 and R.sup.2, together with the carbon atom which they substitute, can also form a 2-oxo-tetrahydrofuryl ring, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 can be identical or different and represent hydrogen, methyl, ethyl or n- or i-propyl and X represents hydrogen, halogen or nitro, or an acid addition salt, alkali metal salt, alkaline earth metal salt, heavy metal salt or hydrate thereof. The heavy metal salts are new.
    一种对抗植物病原细菌的方法,包括向细菌或细菌栖息地施加有效杀菌作用的环丙基-1,4-二氢-4-氧-3-喹啉羧酸衍生物,其化学结构如下:其中A代表直链或支链烷基,含有1至6个碳原子,或>C=CH-基团,R1代表含有1至6个碳原子的烷基部分的烷氧羰基,苄氧羰基,羧基,可选择性取代的氨基甲酰基,氰基或含有1至4个碳原子的烷基磺酰基,R2代表氢,含有1至6个碳原子的烷基部分的烷氧羰基,苄氧羰基,可选择性取代的氨基甲酰基,氰基,氯,乙酰基,含有1至3个碳原子的烷基或苯基,或R1和R2,连同它们替代的碳原子,也可以形成2-氧代-四氢呋喃基环,R3,R4,R5和R6可以相同或不同,并且代表氢,甲基,乙基或n-或i-丙基,X代表氢,卤素或硝基,或其酸加合物盐,碱金属盐,碱土金属盐,重金属盐或水合物。这些重金属盐是新的。
  • Preparation of halogenated quinolonecarboxylic acids
    申请人:Bayer Aktiengesellschaft
    公开号:US04680401A1
    公开(公告)日:1987-07-14
    The invention is a process of making the compounds of the structure ##STR1## wherein R is alkyl with 1-3 carbon atoms, 2-fluoroethyl, phenyl or cyclopropyl, X is halogen, and X.sup.1 and X.sup.2 each independently is hydrogen or halogen. The compounds are useful as intermediates for quinoline antibacterial compounds.
    这项发明是一种制备结构为##STR1##的化合物的过程,其中R是具有1-3个碳原子的烷基,2-氟乙基,苯基或环丙基,X是卤素,而X.sup.1和X.sup.2各自独立地是氢或卤素。这些化合物可用作喹诺酮类抗菌化合物的中间体。
  • Quinolone acids and antibacterial agents containing these compounds
    申请人:Bayer Aktiengesellschaft
    公开号:US04559342A1
    公开(公告)日:1985-12-17
    The invention relates to quinolone carboxylic acids of the formula (I) as defined herein, pharmaceutical compositions containing said quinolone carboxylic acids and the use of said compounds and compositions for treatment of bacterial infection. Also included in the invention are process for the manufacture of the active quinolone carboxylic acids.
    该发明涉及到以下定义的式(I)的喹诺酮羧酸,含有该喹诺酮羧酸的药物组合物,以及用于治疗细菌感染的该化合物和组合物的用途。该发明还包括制造活性喹诺酮羧酸的工艺。
查看更多